Add Yahoo as a preferred source to see more of our stories on Google. The rare neurogenetic disorder affects 1 in 15,000 people For the first time, Colin Farrell has opened up his home and talked ...

Skylark Bio, a clinical-stage biotechnology company developing precision genetic medicines for monogenic disorders, is expanding its pipeline with SKY-AS, a differentiated gene therapy candidate ...

RARE investors are now awaiting an FDA decision on UX111, the company’s one-time gene therapy for Sanfilippo syndrome type A.

Phase 3 Aspire did not achieve the primary endpoint of change from Baseline in Bayley-4 cognitive raw score nor the key secondary endpoint of net ...

Colin Farrell says his personal life has inspired him to launch a new foundation aimed at helping people with intellectual disabilities. The actor, 48, recently launched the Colin Farrell Foundation, ...

According to DelveInsight's estimates, the Angelman syndrome market size in the 7MM is expected to show positive growth during the forecast period (2025–2034), primarily driven by the increasing ...

Angelman syndrome is a rare neurodevelopmental disorder characterized by changes in brain structure, severe intellectual disability, impairments in speech, motor function, epilepsy, sleep, and unique ...

Angelman syndrome has no cure and few treatments but the rare genetic disorder now has the first clinic in the nation dedicated to the condition. The University of North Carolina at Chapel Hill has ...

Angelman syndrome affects roughly 1 in every 20,000 children and it has no approved treatment. Researchers recently published results of early tests of a gene therapy strategy for Angelman syndrome, a ...

This simple picture is challenged by Angelman syndrome, a rare but serious genetic syndrome that impairs brain development. Angelman syndrome checks all the boxes above: delayed brain development, ...

CBF and Pró-Rim bring organ donation onto the field in the 27th round of the Brasileirão Credits: Pró-Rim and CBF DisclosureThe Brazilian Football Confederation (CBF) and the Pró-Rim Foundation wi ...